[go: up one dir, main page]

IL140364A0 - A mutant human hepatitis b viral strain and uses thereof - Google Patents

A mutant human hepatitis b viral strain and uses thereof

Info

Publication number
IL140364A0
IL140364A0 IL14036498A IL14036498A IL140364A0 IL 140364 A0 IL140364 A0 IL 140364A0 IL 14036498 A IL14036498 A IL 14036498A IL 14036498 A IL14036498 A IL 14036498A IL 140364 A0 IL140364 A0 IL 140364A0
Authority
IL
Israel
Prior art keywords
mutant human
human hepatitis
viral strain
viral
strain
Prior art date
Application number
IL14036498A
Other languages
English (en)
Original Assignee
Government Of The Republic Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government Of The Republic Of Singapore filed Critical Government Of The Republic Of Singapore
Publication of IL140364A0 publication Critical patent/IL140364A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14036498A 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof IL140364A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG1998/000046 WO1999066048A1 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Publications (1)

Publication Number Publication Date
IL140364A0 true IL140364A0 (en) 2002-02-10

Family

ID=20429862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14036498A IL140364A0 (en) 1998-06-19 1998-06-19 A mutant human hepatitis b viral strain and uses thereof

Country Status (22)

Country Link
US (1) US6558675B1 (xx)
EP (1) EP1098981A1 (xx)
JP (1) JP2002518014A (xx)
KR (1) KR100498118B1 (xx)
CN (1) CN1322251A (xx)
AR (1) AR020093A1 (xx)
AU (1) AU756866B2 (xx)
BG (1) BG105066A (xx)
BR (1) BR9815913A (xx)
CA (1) CA2330935C (xx)
HU (1) HUP0103409A3 (xx)
IL (1) IL140364A0 (xx)
IS (1) IS5778A (xx)
MX (1) MXPA00012720A (xx)
MY (1) MY118955A (xx)
NO (1) NO20006456L (xx)
NZ (1) NZ508890A (xx)
PL (1) PL192129B1 (xx)
TR (1) TR200003777T2 (xx)
UA (1) UA73476C2 (xx)
WO (1) WO1999066048A1 (xx)
YU (1) YU80600A (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006132598A1 (en) 2005-06-07 2006-12-14 Temasek Life Sciences Laboratory Limited Porcine circovirus type 2 vaccines
EP3708176A1 (en) * 2019-03-15 2020-09-16 Centre National De La Recherche Scientifique -Cnrs- Mutant vsv ectodomain polypeptide and uses thereof
AR120096A1 (es) 2019-09-30 2022-02-02 Gilead Sciences Inc Vacunas para vhb y métodos de tratamiento de vhb
CN113201051B (zh) * 2021-04-27 2022-08-02 复旦大学 一种乙肝病毒表面蛋白突变体及其在抗乙肝病毒中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401987D0 (en) * 1994-02-02 1994-03-30 Imperial College Modified nucleic acid
US5980901A (en) * 1996-09-18 1999-11-09 The Board Of Regents Of The University Of Texas System Viral defective interfering particles and uses thereof

Also Published As

Publication number Publication date
MXPA00012720A (es) 2002-05-08
YU80600A (sh) 2005-06-10
UA73476C2 (en) 2005-08-15
US6558675B1 (en) 2003-05-06
IS5778A (is) 2000-12-19
CA2330935A1 (en) 1999-12-23
NZ508890A (en) 2004-04-30
EP1098981A1 (en) 2001-05-16
BG105066A (en) 2001-09-28
CN1322251A (zh) 2001-11-14
NO20006456L (no) 2001-02-16
PL345573A1 (en) 2001-12-17
HUP0103409A2 (hu) 2001-12-28
MY118955A (en) 2005-02-28
KR100498118B1 (ko) 2005-07-01
AU756866B2 (en) 2003-01-23
BR9815913A (pt) 2001-12-26
JP2002518014A (ja) 2002-06-25
CA2330935C (en) 2005-05-10
HUP0103409A3 (en) 2003-10-28
TR200003777T2 (tr) 2001-06-21
AU7795198A (en) 2000-01-05
WO1999066048A1 (en) 1999-12-23
NO20006456D0 (no) 2000-12-18
KR20010106129A (ko) 2001-11-29
PL192129B1 (pl) 2006-09-29
AR020093A1 (es) 2002-04-10

Similar Documents

Publication Publication Date Title
GB2353529B (en) Mutant herpes simplex viruses and uses thereof
AP9701060A0 (en) Hepatitis B vaccine
HUP9901901A3 (en) Vaccines against hepatitis c
GB9415369D0 (en) Mutant virus
PL345203A1 (en) A vaccine-induced hepatitis b viral strain and uses thereof
AU3238995A (en) Hepatitis a virus receptor and methods of use
PL345573A1 (en) A mutant human hepatitis b viral strain and uses thereof
GB2359083B (en) Mutant herpes simplex viruses and uses thereof
EP0910849A4 (en) CAPABLE FEEDBACK HEADPHONES AND COMPUTER AUDIOMETER PROVIDED WITH SUCH HEADPHONES
AU8751298A (en) Replication-competent recombinant sabin type 1 strain of poliovirus
HUP0101652A3 (en) Hepatitis vaccine
HK1037385A (en) A mutant human hepatitis b viral strain and uses thereof
GB9826687D0 (en) Ballasted covering scale for the handle of a utensil and a utensil provided with a covering scale of that type
IL136514A0 (en) Beta-lipotropin and uses thereof
HK1037211A (en) A vaccine-induced hepatitis b viral strain and uses thereof
GB2357688B (en) Rein grip and a rein including the rein grip
AU3145999A (en) A and b apicularene
SI1073462T1 (sl) Kombinirano cepivo proti hepatitisu A in hepatitisu B
AU6006600A (en) A baby gym and a clamp unit
ZA95105B (en) Red-dot HIV 1 and 2
TW341209U (en) A baby walking chair and carriage
SI0810877T1 (en) Hepatitis b vaccine
ZA95524B (en) Creep resistant iron-chromium-aluminum alloy and article thereof
GB9725241D0 (en) Hiv vaccine
GB9703202D0 (en) HIV vaccine